Abstract 4012: Preclinical development of SHP2 allosteric inhibitor ICP-189
Liang, Ruixia, Gao, Yingxiang, Yang, Fangfang, Han, Yingrui, Wang, Zuopeng, Liu, Richard, Wang, Charles Ying, Zhang, Jason Bin, Chen, Xiangyang, Ouyang, Davy Xuesong
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
Abstract 3427: ICP-490 is a highly potent and selective IKZF1/3 degrader with robust anti-tumor activities against multiple myeloma and non-Hodgkin’s lymphoma
Liang, Ruixia, Pang, Yucheng, Han, Yingrui, Xu, Haipeng, Wang, Zuopeng, Liu, Richard, Wang, Charles Ying, Zhang, Jason Bin, Chen, Xiangyang, Ouyang, Davy Xuesong
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
Abstract 6187: ICP-723 is a potent pan-TRK Inhibitor with robust anti-tumor activities against wild-type and acquired drug-resistant mutations of NTRK fusions
Liang, Ruixia, Zhou, Chao, Han, Yingrui, Lu, Prince, Wang, Charles Ying, Wang, Zuopeng, Liu, Richard, Kong, Norman, Zhang, Jason Bing, Cui, Jasmine Jisong, Ouyang, Davy Xuesong
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Multi-flux test method aiming at plate and strip temperature-dependent shape change phenomenon
YANG TINGSONG, HAN YINGRUI, HE ANRUI, YUAN TIEHENG, SUN WENQUAN, LIU CHAO
Year of Publication 20.10.2023
Get full text
Year of Publication 20.10.2023
Patent
Curcumin dicaprate suspension injection and preparation method and application thereof
WEI XIAOLAN, YAO GUANGYIN, QUAN LIHUI, LIAO YONGHONG, LIU CHUNYU, HAN YINGRUI
Year of Publication 29.05.2013
Get full text
Year of Publication 29.05.2013
Patent